Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C

Gut

Volumn 51, Issue 1, 2002, Pages 89-94

  Hickman, I J ^a   Clouston, A D ^b   Macdonald, G A ^b   Purdie, D M ^c   Prins, J B ^a   Ash, S ^a   Jonsson, J R ^b   Powell, Elizabeth E ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; LIVER BIOPSY; LIVER FATTY DEGENERATION; LIVER FIBROSIS; MALE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM; STEATOSIS; STELLATE CELL; TREATMENT OUTCOME; VIRUS GENOME; WEIGHT REDUCTION;

ADULT; AGED; ALANINE TRANSAMINASE; BODY MASS INDEX; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INSULIN; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; WEIGHT LOSS;

EID: 0036294003     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.1.89     Document Type: Article

References (27)

1. Randomised trial of interferon alfa-2b and ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
2. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
3. Interfereon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
4. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
5. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
6. Non-alcaholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
7. Steatosis on liver biopsy in patients with hepatitis C is associated with obesity and diabetes, but not with life-time alcohol use
8. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
9. Histological grading and staging of chronic hepatitis
10. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy
11. Homeostasis model of assessment: Insulin resistance and β-cell function arising from fasting plasma glucose and insulin concentrations in man
12. Waist circumference as a measure for indicating need for weight management
13. The relationship between body mass index and waist circumference: Implications for estimates of the population prevalence of overweight
14. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients
15. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients
16. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice
17. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype
18. Steatosis and chronic hepatitis C: Analysis of fibrosis and stellate cell activation
19. Apoptosis of hepatic stellate cells: Involvement in resolution of biliary fibrosis and regulation by soluble growth factors
20. Effect of weight reduction on hepatic abnormalities in overweight patients
21. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
22. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion
23. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production
24. Altered alveolar macrophage function in calorie-restricted rats
25. Diet modulates Th-1 and Th-2 cytokine production in the peripheral blood of lupus-prone mice
26. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes
27. Diet, behavior-modification, and exercise: A review of obesity treatments from a long-term perspective